Cancer-related molecular mechanisms research
Cancer-related molecular mechanisms research is a research topic within Cancer Research. Science Explorer counts 70k research works in it since 1950. 20.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of long noncoding RNAs (lncRNAs) in cancer, development, and genome regulation. It covers topics such as the transcriptional landscape, epigenetic regulation, chromatin modification, competing endogenous RNA networks, and the impact of lncRNAs on cell differentiation. The papers also delve into the functional classification and molecular mechanisms of lncRNAs, highlighting their significance in human diseases.
- Long Noncoding RNAs
- Cancer
- RNA Regulation
- Epigenetic Regulation
- Transcriptional Landscape
- Cell Differentiation
- Chromatin Modification
- Competing Endogenous RNA
- Genome Regulation
- Non-coding RNA Networks
- Research works
- 70k fractional, since 1950
- In the world top 10%
- 14k per year above
- Top-10% rate
- 20.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +75% the tick is no change
Which countries lead Cancer-related molecular mechanisms research research?
By volume, China and the United States publish the most (11k and 2.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 11k works
- 2 United States 2.1k works
- 3 India 611 works
- 4 Iran 540 works
- 5 Japan 324 works
- 6 Germany 302 works
- 7 Italy 292 works
- 8 South Korea 286 works
- 9 United Kingdom 246 works
- 10 Egypt 203 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cancer-related molecular mechanisms research research?
By volume in 2022–2025, Nanjing Medical University publishes the most Cancer-related molecular mechanisms research research, followed by Sun Yat-sen University and Central South University.
By volume, 2022–2025
- 1 Nanjing Medical University China 136 works
- 2 Sun Yat-sen University China 134 works
- 3 Central South University China 134 works
- 4 China Medical University China 114 works
- 5 Chinese Academy of Medical Sciences & Peking Union Medical College China 101 works
- 6 Harbin Medical University China 97 works
- 7 Shanghai Jiao Tong University China 88 works
- 8 Huazhong University of Science and Technology China 85 works
- 9 Zhejiang University China 84 works
- 10 Fujian Medical University China 81 works
Who are the leading researchers in Cancer-related molecular mechanisms research?
The most-cited researchers publishing on Cancer-related molecular mechanisms research include Todd R. Golub and Gad Getz.
- 1 Todd R. Golub 6.8k citations
- 2 Gad Getz 6.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cancer-related molecular mechanisms research research done?
The largest centres of Cancer-related molecular mechanisms research research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China). Among places with at least 20 works in it, it is an unusually large share of all research in Baise City, Nantong and Zunyi.
Largest cities, 2022–2025
Where it is the local speciality
- Baise CityCN · 23.3 works19×
- NantongCN · 117.0 works15×
- ZunyiCN · 49.7 works14×
Location quotient: how much more of its research is in Cancer-related molecular mechanisms research than the world average.
Where is the best place to study Cancer-related molecular mechanisms research?
Among universities, judged by research, Harbin Medical University, Nanjing Medical University and China Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harbin Medical University China | 74.0 | 22.6% | 28.1× | 98 | +203.8% |
| 2 | Nanjing Medical University China | 71.9 | 22.7% | 15.5× | 136 | +121.6% |
| 3 | China Medical University China | 71.4 | 25.3% | 20.6× | 114 | +101.6% |
| 4 | Guangzhou Medical University China | 70.3 | 24.7% | 13.5× | 62 | +153.0% |
| 5 | Shandong First Medical University China | 70.1 | 23.0% | 12.1× | 54 | +208.8% |
| 6 | Dalian Medical University China | 69.2 | 27.3% | 12.3× | 40 | +166.4% |
| 7 | Shanghai Medical College of Fudan University China | 68.3 | 34.6% | 13.1× | 18 | +133.3% |
| 8 | Wenzhou Medical University China | 67.7 | 18.3% | 11.1× | 66 | +236.3% |
| 9 | Kunming Medical University China | 66.9 | 18.7% | 19.4× | 59 | +230.4% |
| 10 | Anhui Medical University China | 66.6 | 24.5% | 12.6× | 64 | +103.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cancer-related molecular mechanisms research research growing?
Output in 2018–2022 was 75% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Cancer-related molecular mechanisms research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.